Warning: Use of undefined constant translate_tb_widget_register - assumed 'translate_tb_widget_register' (this will throw an Error in a future version of PHP) in /home/customer/www/diabetesdailypost.com/public_html/wp-content/plugins/translate-this-button/ttb-sidebar-widget.php on line 129

Warning: Declaration of titlemenuwalker::start_el(&$output, $item, $depth, $args) should be compatible with Walker_Nav_Menu::start_el(&$output, $item, $depth = 0, $args = NULL, $id = 0) in /home/customer/www/diabetesdailypost.com/public_html/wp-content/themes/frailespatique/functions.php on line 0

Warning: Declaration of kohette_combomenu_walker::start_el(&$output, $category, $depth, $args) should be compatible with Walker_Category::start_el(&$output, $category, $depth = 0, $args = Array, $id = 0) in /home/customer/www/diabetesdailypost.com/public_html/wp-content/themes/frailespatique/widgets/kohette-combo-menu.php on line 0

Warning: Use of undefined constant ktt_theme_js - assumed 'ktt_theme_js' (this will throw an Error in a future version of PHP) in /home/customer/www/diabetesdailypost.com/public_html/wp-content/themes/frailespatique/functions.php on line 813

Warning: session_start(): Cannot start session when headers already sent in /home/customer/www/diabetesdailypost.com/public_html/wp-content/plugins/seamless-donations/legacy/dgx-donate.php on line 975
Diabetes Health | Diabetes Daily Post
Diabetes Health
Understanding Soliqua 100/33™and Xultophy 100/3.6™: Once-Daily Injectables
Learning about: Soliqua 100/33™ and Xultophy 100/3.6™: the new once-daily injectable GLP-1 receptor agonist/basal insulin combination pens Soliqua 100/33 and Xultophy 100/3.6 are two new injectable combination products approved by the U.S. Food and Drug Administration (FDA) in November of 2016. They are used for the treatment of type 2 diabetes (T2DM) in adults who are not well-controlled on metformin or oral medications and either a basal (long-acting) insulin or a glucagon-like peptide 1 receptor...
Learning About Diabulimia
Learning About Diabulimia Most people are familiar with eating disorders such as anorexia, bulimia and binge eating disorder, but few are familiar with an eating disorder that is unique to patients with type 1 diabetes (T1DM). ED-DMT1, or what the media has dubbed “diabulimia,” is an eating disorder where patients with T1DM will purposely stop taking or significantly reduce their insulin doses to lose weight. Without enough insulin,patients with T1DM will lose calories through the...
Understanding The Story Behind Type 1.5 Diabetes
The Story Behind Type 1.5 Diabetes Type 1 and type 2 diabetes are the most well-known forms of diabetes. However, about 10% of people with diabetes have type 1.5 diabetes. Type 1.5 diabetes is also sometimes called LADA which stands for latent autoimmune diabetes in adults. Type 1 diabetes (T1DM)usually occurs during childhood but can occur later in life. It is known as an autoimmune disorder. Autoimmune disorders occur when the body uses proteins to...
1 2 3 4 >

Global Translator